logo-loader
RNS
Beacon Rise Holdings PLC

Beacon Rise Holdings - Update in relation to Ergotec

RNS Number : 2656Q
Beacon Rise Holdings PLC
11 August 2026
 

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation

 

11 August 2026

 

Beacon Rise Holdings Plc

("Beacon Rise" or the "Company")

 

Update in relation to the Proposed Ergotec Acquisition

 

On 29 September 2025 Beacon Rise (LSE: BRS) announced that it had entered non-binding heads of terms save for exclusivity and other customary terms in relation to the proposed acquisition of Ergotec Health LLP ("Ergotec Health") by the Company for a consideration of approximately £0.95 million (the "Proposed Ergotec Acquisition").

 

Following careful consideration, relating to key commercial terms, the board of directors of Beacon Rise (the "Board" or the "Directors") have concluded that it would not be in the best interest of the Company's shareholders to pursue the Proposed Ergotec Acquisition. Accordingly, the Board has terminated discussions in relation to the Proposed Ergotec Acquisition.

 

As noted in previous announcements, the Company intends to proceed with Cancellation and Admission should a final binding acquisition agreement be agreed in relation to at least one of the proposed acquisitions. Accordingly, the Board remains committed to finalising due diligence in relation to the previously announced Proposed Chiropractor Acquisition as well as the necessary transaction documentation in relation to Admission.

 

The Board intends to create an integrated physical healthcare services provider that is expected to provide physiotherapy, chiropractic and sports rehabilitation services to patients in the United Kingdom. The Board intends to achieve this primarily through implementing a structured buy-and-build strategy with the Proposed Chiropractor Acquisition representing the beginning of this strategy. With this in mind, the Board intends to explore other related potential acquisitions post-Admission, instead of seeking Admission contemporaneously with the completion of several related acquisitions. The Board also intends to supplement its growth strategy through pursuing relevant organic growth opportunities, where applicable.

 

Temporary suspension of listing and trading of Ordinary Shares

 

The Proposed Chiropractor Acquisition is classified as an "initial transaction" under UK Listing Rules ("UKLR") 13.4. In accordance with UKLR 21.1.4 and 21.3, the Company ordinary shares of £0.0001 each (ISIN: GB00BMC0V753) will remain suspended from its listing on the equity shares (shell companies) category of the Official List of the FCA and from trading on the Main Market of the London Stock Exchange.

 

Should final terms for the Proposed Chiropractor Acquisition be agreed, the Company will issue an announcement with further details pursuant to UKLR 13.4.22R and UKLR 13.4.23R.

 

There can be no certainty that the Proposed Chiropractor Acquisition will successfully complete, nor as to the final terms or timing of the Proposed Chiropractor Acquisition. If the Proposed Chiropractor Acquisition does not complete for any reason, it is expected that the suspension of the Company's listing on the Official List will be lifted, subject to FCA approval, and trading in the Company's shares on the Main Market of the London Stock Exchange will recommence.

 

The Company will release further announcements as and when appropriate.

 

Unless otherwise defined, definitions contained in this announcement have the same meaning as set out in the Company's notification on 29 September 2025 at 8:11 a.m.

 

Enquiries:

Beacon Rise Holdings Plc

Xiaobing Wang, Chief Executive Officer & Director

 

info@beaconrise.uk



Allenby Capital Limited - Sponsor and Financial Adviser

John Depasquale / Vivek Bhardwaj / Ashur Joseph

 Tel: +44 (0)20 3328 5656

info@allenbycapital.com



LDC Nominee Secretary Limited - Company Secretary

 

beaconrisecss@lawdeb.com

Legal Entity Identifier (LEI)

2138007PIYMZMBWD4M27

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FUREAXPFFFXKEFA
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read